KYLYS is a Life Science Spin-off from the University of Geneva founded in march 2017. Passionate about science and biotechnology, we are committed to developing a unique technology to deliver highly effective and safe products based on hyaluronic acid (HA).
Our products are aesthetic (KYLYS Aesthetics) and medical (KYLYS).
Available commercial products of water-soluble polymers suffer from a very short body lifetime. Their excessively fast elimination is a clear drawback. Our Product HA-L-PNIPAM is an entirely new biocompatible and biodegradable gel extremely easily injectable as a fluid gel at room temperature. It has an exceptional ability to form in the tissue, at body temperature, microgel structures providing unprecedented durable effect and absence of migration from the injection site. The microgel structures formed by HA-L-PNIPAM upon exposition to body temperature act as barriers against degradation by endogenous enzymes or oxidation.